17 Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$448K	Buy	3,565 +650	+22%	+$81.7K	0.26%	102
2025 Q1	$322K	Buy	2,915 +1,205	+70%	+$133K	0.21%	119
2024 Q4	$233K	Sell	1,710 -4,136	-71%	-$565K	0.15%	123
2024 Q3	$674K	Buy	5,846 +2,881	+97%	+$332K	0.44%	72
2024 Q2	$408K	Buy	+2,965	New	+$408K	0.29%	93